Welcome to MississippiLifeScience.com
MississippiLifeScience.com is part of a specialized network of state- and province-based biotechnology, medical device,
and life science sites that includes more than 4,500 biotechnology, medical device, pharmaceutical companies,
non-profit research institutions, universities and supporting service sector companies across the U.S. and Canada.
This network addresses the growing informational and service needs of companies, patients, educators and others in
their respective states while providing clients the opportunity to cost effectively
advertise their job openings, events, facility availability and other services at the state level,
regionally or nationwide. We welcome your comments, suggestions and requests for informational content and supporting
services.
 More...
Destination Mississippi
Are you considering a move to Mississippi? Relocating your business to
Mississippi? Starting a company? Or just interested in Mississippi?
This section will answer many of your questions regarding the life science industry in Mississippi, the province's
economy, tax structure and cost of living, education, transportation, climate, recreational opportunities, history,
industry resources, and more.
More...
|
|
|
Local News...
Free News Release Posting & Archiving Service
- The CYPHER(R) Stent outperforms the Taxus(R) Stent in people with diabetes In patients with diabetes, the CYPHER(R) Sirolimus-eluting Coronary Stent outperformed the Taxus(R) Stent with lower rates of in-segment restenosis, target lesion revascularization and major adverse events at nine months according to clinical data.
Johnson & Johnson August 28, 2008
- Monsanto and Evogene collaborate on yield and stress research Monsanto Company and Evogene have entered into a five-year research and development collaboration focused on identifying key plant genes related to yield, environmental stress and fertilizer utilization.
Monsanto Company August 28, 2008
- Amgen alters anemia drug discounts Amgen is halting some pricing practices that critics say were contributing to overuse of its flagship anemia drug Aranesp at a time of mounting concerns about the product's safety.
The New York Times August 27, 2008 Andrew Pollack
- CYPHER SELECT(R) Plus Sirolimus-eluting Coronary Stent receives CE Mark approval Cordis Corporation announced that it has received CE mark approval to market the CYPHER SELECT(R) Plus Sirolimus-eluting Coronary Stent for the treatment of acute myocardial infarction (AMI), more commonly known as a heart attack.
Johnson & Johnson August 27, 2008
- Amylin Pharmaceuticals and Eli Lilly provide context for FDA alert for BYETTA Amylin Pharmaceuticals and Eli Lilly and Company in a conference call provided context and additional information regarding the August 18, 2008 U.S. Food and Drug Administration (FDA) update to a prior alert for BYETTA(R) (exenatide) injection referencing pancreatitis.
Amylin Pharmaceuticals, Inc. August 26, 2008
More... | Submit News Release | National News
|
New Job Postings...
Free Job Posting Trial Offer
More... |
Job Advertising...
| About Job Postings...
|
New Facilities Available...
ATC clean room constructors...validation guaranteed!
More... |
Facility Advertising...
|
Upcoming Events...
Free Event Posting Service
 More... |
Submit Event |
Event Advertising...
|
|
Learn About Mississippi's BioHistory
Why is there a biotechnology industry in Mississippi? Will the industry continue
to grow in Mississippi? What do other states have? Each state has a unique story
that explains why a given industry has developed in a specific region and not in others.
Through Mississippi BioHistory, you can learn about the scientists,
institutions, political leaders, and significant events that have shaped and are still shaping
the biotechnology, medical device and life science industries in the state of Mississippi.
More...
BioEvolution Posters
More...
Your Guide to Reporting Problems to FDA
Consumers play an important public health role by reporting to the Food and
Drug Administration (FDA) any adverse events (unexpected side effects) after
using a medical product, or other problems with any products that the agency
regulates.
Timely reporting allows the agency to take prompt action. There are a
number of ways you can report problems to the agency, depending on the type of
problem and product.
More...
BioFact
(1834) - Thomas Malthus, publisher of "Principle of Population," arguing that the world's population will increase faster than the food supply, died Bath, England.
It's a Small World
|
| |
Pollen Grain
| |
Science Quote
"The things that will destroy us are: politics without principle; pleasure without conscience; wealth without work; knowledge without character; business without morality; science without humanity; and worship without sacrifice. "
| - |
Mahatma Gandhi, Spiritual/political leader
|
|
(1869-1948)
|
|
